Terms: = Gastric cancer AND FGFR4, CD334, 2264, ENSG00000160867, P22455, MGC20292, TKF, JTK2 AND Treatment
17 results:
1. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
2. Antitumor effect of luteolin proven by patient-derived organoids of gastric cancer.
Hao X; Zu M; Ning J; Zhou X; Gong Y; Han X; Meng Q; Li D; Ding S
Phytother Res; 2023 Nov; 37(11):5315-5327. PubMed ID: 37469042
[TBL] [Abstract] [Full Text] [Related]
3. mTOR pathway gene mutations predict response to immune checkpoint inhibitors in multiple cancers.
Cheng L; Wang Y; Qiu L; Chang Y; Lu H; Liu C; Zhang B; Zhou Y; Bai H; Xiong L; Zhong H; Nie W; Han B
J Transl Med; 2022 May; 20(1):247. PubMed ID: 35642038
[TBL] [Abstract] [Full Text] [Related]
4. The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors.
Jin Y; Chen DL; Wang F; Yang CP; Chen XX; You JQ; Huang JS; Shao Y; Zhu DQ; Ouyang YM; Luo HY; Wang ZQ; Wang FH; Li YH; Xu RH; Zhang DS
Mol Cancer; 2020 Oct; 19(1):154. PubMed ID: 33126883
[TBL] [Abstract] [Full Text] [Related]
5. Expression and clinical significance of paired- related homeobox 1 and Smad2 in gastric cancer.
Yang Z; Huang WX; Wang S; Yao JB; Da M
Eur J Cancer Prev; 2021 Mar; 30(2):154-160. PubMed ID: 32868636
[TBL] [Abstract] [Full Text] [Related]
6. fgfr4 Gly388Arg Polymorphism Affects the Progression of gastric cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition.
Ye Y; Li J; Jiang D; Li J; Xiao C; Li Y; Han C; Zhao C
Cancer Res Treat; 2020 Oct; 52(4):1162-1177. PubMed ID: 32599983
[TBL] [Abstract] [Full Text] [Related]
7. The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladder.
Roskoski R
Pharmacol Res; 2020 Jan; 151():104567. PubMed ID: 31770593
[TBL] [Abstract] [Full Text] [Related]
8. Atractylenolide III Enhances the Anti-Neoplastic Efficacy of Docetaxel in gastric cancer Cell by Inhibiting Fibroblast Growth Factor Receptors 1, -2, and -4 Expression.
Ji Y; Kang Z; Kang N; Zhao Y; Guo Q; Chen Y
J Environ Pathol Toxicol Oncol; 2019; 38(3):217-227. PubMed ID: 31679309
[TBL] [Abstract] [Full Text] [Related]
9. Chemo-resistant gastric cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus.
Liu JB; Jian T; Yue C; Chen D; Chen W; Bao TT; Liu HX; Cao Y; Li WB; Yang Z; Hoffman RM; Yu C
Anticancer Res; 2019 Apr; 39(4):1689-1698. PubMed ID: 30952707
[TBL] [Abstract] [Full Text] [Related]
10. The miR-29c-KIAA1199 axis regulates gastric cancer migration by binding with WBP11 and PTP4A3.
Wang L; Yu T; Li W; Li M; Zuo Q; Zou Q; Xiao B
Oncogene; 2019 Apr; 38(17):3134-3150. PubMed ID: 30626935
[TBL] [Abstract] [Full Text] [Related]
11. Therapeutics Targeting FGF Signaling Network in Human Diseases.
Katoh M
Trends Pharmacol Sci; 2016 Dec; 37(12):1081-1096. PubMed ID: 27992319
[TBL] [Abstract] [Full Text] [Related]
12. The over-expression of fgfr4 could influence the features of gastric cancer cells and inhibit the efficacy of PD173074 and 5-fluorouracil towards gastric cancer.
Li J; Ye Y; Wang M; Lu L; Han C; Zhou Y; Zhang J; Yu Z; Zhang X; Zhao C; Wen J; Kan Q
Tumour Biol; 2016 May; 37(5):6881-91. PubMed ID: 26662569
[TBL] [Abstract] [Full Text] [Related]
13. The genomic landscape of oesophagogastric junctional adenocarcinoma.
Chong IY; Cunningham D; Barber LJ; Campbell J; Chen L; Kozarewa I; Fenwick K; Assiotis I; Guettler S; Garcia-Murillas I; Awan S; Lambros M; Starling N; Wotherspoon A; Stamp G; Gonzalez-de-Castro D; Benson M; Chau I; Hulkki S; Nohadani M; Eltahir Z; Lemnrau A; Orr N; Rao S; Lord CJ; Ashworth A
J Pathol; 2013 Nov; 231(3):301-10. PubMed ID: 24308032
[TBL] [Abstract] [Full Text] [Related]
14. Combination of the fgfr4 inhibitor PD173074 and 5-fluorouracil reduces proliferation and promotes apoptosis in gastric cancer.
Ye YW; Hu S; Shi YQ; Zhang XF; Zhou Y; Zhao CL; Wang GJ; Wen JG; Zong H
Oncol Rep; 2013 Dec; 30(6):2777-84. PubMed ID: 24126887
[TBL] [Abstract] [Full Text] [Related]
15. FGF receptors: cancer biology and therapeutics.
Katoh M; Nakagama H
Med Res Rev; 2014 Mar; 34(2):280-300. PubMed ID: 23696246
[TBL] [Abstract] [Full Text] [Related]
16. [Gene expression profiling using oligonucleotide microarray in atrophic gastritis and intestinal metaplasia].
Kim KR; Oh SY; Park UC; Wang JH; Lee JD; Kweon HJ; Kim SY; Park SH; Choi DK; Kim CG; Choi SH
Korean J Gastroenterol; 2007 Apr; 49(4):209-24. PubMed ID: 17464166
[TBL] [Abstract] [Full Text] [Related]
17. Up-regulation and co-expression of fibroblast growth factor receptors in human gastric cancer.
Shin EY; Lee BH; Yang JH; Shin KS; Lee GK; Yun HY; Song YJ; Park SC; Kim EG
J Cancer Res Clin Oncol; 2000 Sep; 126(9):519-28. PubMed ID: 11003564
[TBL] [Abstract] [Full Text] [Related]
